Concepedia

E. Liang

EL

Statistics

Publications

2

Citations

69

H-Index

2

Active since

2013

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

E. Liang is an author at Novartis (Switzerland) specializing in immunology, immunogenicity of therapeutic antibodies, and interleukin 17 inhibition.

Publications per year

2013–2016

2

Publications

2

Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis

Kristian Reich, Andrew Blauvelt, April W. Armstrong et al. · British Journal of Dermatology · 2016 · 59 citations

, , +17

SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients

Ulf Klein, E. Liang, Beate Vogel et al. · Annals of the Rheumatic Diseases · 2013 · 10 citations

, , +17

1–2 of 2